Abstract

ObjectivesMicrofluidic perfusion systems are used for assessing cell and tissue function while assuring cellular viability. Low perfusate flow rates, desired both for conserving reagents and for extending the number of channels and duration of experiments, conventionally depend on peristaltic pumps to maintain flow yet such pumps are unwieldy and scale poorly for high-throughput applications requiring 16 or more channels. The goal of the study was to develop a scalable multichannel microfluidics system capable of maintaining and assessing kinetic responses of small amounts of tissue to drugs or changes in test conditions.MethodsHere we describe the BaroFuse, a novel, multichannel microfluidics device fabricated using 3D-printing technology that uses gas pressure to drive large numbers of parallel perfusion experiments. The system is versatile with respect to endpoints due to the translucence of the walls of the perifusion chambers, enabling optical methods for interrogating the tissue status. The system was validated by the incorporation of an oxygen detection system that enabled continuous measurement of oxygen consumption rate (OCR).ResultsStable and low flow rates (1–20 μL/min/channel) were finely controlled by a single pressure regulator (0.5–2 psi). Control of flow in 0.2 μL/min increments was achieved. Low flow rates allowed for changes in OCR in response to glucose to be well resolved with very small numbers of islets (1–10 islets/channel). Effects of acetaminophen on OCR by precision-cut liver slices of were dose dependent and similar to previously published values that used more tissue and peristaltic-pump driven flow.ConclusionsThe very low flow rates and simplicity of design and operation of the BaroFuse device allow for the efficient generation of large number of kinetic profiles in OCR and other endpoints lasting from hours to days. The use of flow enhances the ability to make measurements on primary tissue where some elements of native three-dimensional structure are preserved. We offer the BaroFuse as a powerful tool for physiological studies and for pharmaceutical assessment of drug effects as well as personalized medicine.

Highlights

  • Low flow rates allowed for changes in oxygen consumption rate (OCR) in response to glucose to be well resolved with very small numbers of islets (1–10 islets/channel)

  • The very low flow rates and simplicity of design and operation of the BaroFuse device allow for the efficient generation of large number of kinetic profiles in OCR and other endpoints lasting from hours to days

  • Dynamic flow-through methods offer a combination of optimal tissue maintenance with assay endpoints yet such methods typically depend on peristaltic or syringe pumps and complex “plumbing” schemes that scale poorly for high-throughput applications. Microfluidics approaches, such as those based on soft lithography, have not provided pharmacologists with adequate and disseminated tools that are practical to use [6]. For such applications as pharmaceutical drug screening or toxicity testing we describe and validate a simplified and scalable solution, the BaroFuse, that we have designed based on our previous flow-through cell and tissue perfusion methods [7], and utilized powerful but easy to implement 3D printing methods [8]

Read more

Summary

Introduction

Dynamic flow-through methods offer a combination of optimal tissue maintenance with assay endpoints yet such methods typically depend on peristaltic or syringe pumps and complex “plumbing” schemes that scale poorly for high-throughput applications. Microfluidics approaches, such as those based on soft lithography, have not provided pharmacologists with adequate and disseminated tools that are practical to use [6]. For such applications as pharmaceutical drug screening or toxicity testing we describe and validate a simplified and scalable solution, the BaroFuse, that we have designed based on our previous flow-through cell and tissue perfusion methods [7], and utilized powerful but easy to implement 3D printing methods [8]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call